Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
45.15
-0.85 (-1.85%)
Oct 23, 2026, 4:00 PM EDT - Market closed

Spruce Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
130931711926105
Market Cap Growth
63.87%437.50%-85.46%361.35%-75.29%-81.46%
Enterprise Value
4184-3916-5819
Last Close Price
45.1587.1131.50219.7582.31334.50

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--3.5311.82--
PB Ratio
1.482.190.601.560.380.94
P/TBV Ratio
1.552.190.601.560.380.94

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
---1.62--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.090.020.100.060.090.06
Net Debt / Equity Ratio
-1.06-1.13-1.25-1.20-1.06-0.74
Net Debt / EBITDA Ratio
2.271.690.641.771.541.96
Net Debt / FCF Ratio
2.071.450.642.761.752.29
Asset Turnover
--0.070.11--
Quick Ratio
8.785.112.543.946.3510.03
Current Ratio
9.235.172.904.186.7210.36
Return on Equity (ROE)
-105.98%-109.24%-100.70%-66.10%-51.35%-32.43%
Return on Assets (ROA)
-40.03%-36.41%-47.06%-34.28%-27.86%-18.17%
Return on Capital Employed (ROCE)
-43.50%-66.60%-187.40%-65.40%-64.60%-35.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-79.84%-41.79%-305.73%-40.17%-178.61%-40.41%
FCF Yield
-32.96%-35.74%-322.61%-27.90%-161.25%-34.37%
Buyback Yield / Dilution
-149.78%-39.34%-7.14%-63.68%-0.71%-289.93%